{"url_path":"/sec/imux/8-k/2026-05-19/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-19","source_url":"https://www.sec.gov/Archives/edgar/data/1280776/0001193805-26-000645-index.html","accession_number":"0001193805-26-000645","cik":"0001280776","ticker":"IMUX","issuer_name":"IMMUNIC, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1280776/0001193805-26-000645-index.html","primary_entity_key":"0001280776","primary_entity_name":"IMMUNIC, INC."},"word_count":76,"has_tables":true,"body_markdown":"**Item 9.01. Financial Statements and Exhibits**\n\n \n\n**Exhibit**\n**Description**\n\n99.1\n[Press Release dated May 19, 2026.](e665479_ex99-1.htm)\n\n104\n\nCover Page to this Current Report on Form 8-K in Inline\nXBRL.\n\n \n\n \n\n \n\n  \n\nSIGNATURES\n\n** **\n\nPursuant to the requirements of the Securities Exchange\nAct of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.\n\n \n\nDated: May 19, 2026\n\n**Immunic, Inc.**\n\n \n \n \n\n \nBy:\n*/s/ Daniel Vitt*\n\n \n \nDaniel Vitt\n\n \n \nChief Executive Officer"}